mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
9e-07 |
mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
-0.16 |
1e-06 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-06 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-06 |
mRNA |
Cerulenin |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-06 |
mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
5e-06 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
5e-06 |
mRNA |
BRD-K92856060 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
6e-06 |
mRNA |
lovastatin |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
9e-06 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-05 |